A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  International Journal of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.12.1.87PMID 9454891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.

  1996cited by this paper
• Requirement of transforming growth factor-beta (TGF-beta) type II receptor for TGF-beta-induced proliferation and growth inhibition.

  1996cited by this paper
• Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells*

  1996cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Signaling Activity of Homologous and Heterologous Transforming Growth Factor-β Receptor Kinase Complexes (*)

  1995cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995cited by this paper
• Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

  1995cited by this paper
• Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.

  1995cited by this paper
• Signaling by the transforming growth factor-beta receptors.

  1995cited by this paper
• Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription.

  1995cited by this paper
• Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

  1995cited by this paper
• Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines.

  1995cited by this paper
• Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line.

  1994cited by this paper
• Mechanism of activation of the TGF-beta receptor.

  1994cited by this paper
• A transforming growth factor beta type I receptor that signals to activate gene expression.

  1994cited by this paper
• Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.

  1994cited by this paper
• Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

  1994cited by this paper
• Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

  1994cited by this paper
• Receptors for transforming growth factor-beta.

  1994cited by this paper
• A dominant-negative receptor for type beta transforming growth factors created by deletion of the kinase domain.

  1993cited by this paper
• Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region

  1993cited by this paper
• Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.

  1993cited by this paper
• Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.

  1993cited by this paper
• Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

  1993cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector

  1992cited by this paper
• Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells.

  1989cited by this paper
• Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.

  1988cited by this paper
• Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells.

  1988cited by this paper
• Determination of cell number in monolayer cultures.

  1986cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells

  2012cites this paper
• Contribution of Bone Tissue Modulus to Breast Cancer Metastasis to Bone

  2011cites this paper
• Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.

  2011cites this paper
• Mutant p53 Disrupts Role of ShcA Protein in Balancing Smad Protein-dependent and -independent Signaling Activity of Transforming Growth Factor-β (TGF-β)*

  2011cites this paper
• Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy.

  2009cites this paper
• DNA Methylation and Histone Deacetylation Inhibitors as Potential Therapeutic Agents for the Reconstitution of TGF-β Signaling in Breast Cancer

  2008cites this paper
• Modulating TGF-β Receptor Signaling: A Novel Approach of Cancer Therapy

  2008cites this paper
• Transforming Growth Factor-β Signaling in Prostate Stromal Cells Supports Prostate Carcinoma Growth by Up-regulating Stromal Genes Related to Tissue Remodeling

  2007cites this paper
• Abrogation of TGFbeta signaling induces apoptosis through the modulation of MAP kinase pathways in breast cancer cells.

  2007cites this paper
• Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling.

  2007cites this paper
• Abrogation of TGFβ Signaling Induces Apoptosis Through the Modulation of MAP Kinase Pathways in Breast Cancer Cells

  2007cites this paper
• Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublines

  2005cites this paper
• Disruption of LTBP-4 function reduces TGF- (cid:1) activation and enhances BMP-4 signaling in the lung

  2004cites this paper
• Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung

  2004cites this paper
• Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.

  2001cites this paper
• Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in‐situ and invasive carcinomas

  2000cites this paper
• Overexpression of a dominant-negative type II TGFβ receptor tagged with green fluorescent protein inhibits the effects of TGFβ on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity

  1999cites this paper
• Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity.

  1999cites this paper